Histone Deacetylase (HDAC) inhibitors as potential anticancer drugs in Neuroendocrine Carcinomas (NEC) of cervix and endometrium

被引：0
|
作者：
Rito, M. [1 ]
Silva, F. [1 ]
Felix, A. [1 ]
机构：
[1] IPO Lisboa Francisco Gentil, Serv Anat Patol, Lisbon, Portugal
来源：
VIRCHOWS ARCHIV | 2015年 / 467卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
OFP-05-005
引用
收藏
页码：S15 / S16
页数：2
相关论文
共 50 条
  • [31] The activity of antiepileptic drugs as histone deacetylase inhibitors
    Eyal, S
    Yagen, B
    Sobol, E
    Altschuler, Y
    Shmuel, M
    Bialer, M
    EPILEPSIA, 2004, 45 (07) : 737 - 744
  • [32] Novel hydroxamic acids as potent inhibitors of histone deacetylase (HDAC).
    Curtin, ML
    Garland, RB
    Frey, RR
    Heyman, HR
    Michaelides, MR
    Li, JL
    Pease, LJ
    Glaser, KB
    Marcotte, PA
    Davidsen, SK
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U28 - U28
  • [33] Selective Inhibitors of Histone Deacetylase 10 (HDAC-10)
    Pojani, Eftiola
    Barlocco, Daniela
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (11) : 2306 - 2321
  • [34] Histone deacetylase inhibitors as new cancer drugs
    Marks, PA
    Richon, VM
    Breslow, R
    Rifkind, RA
    CURRENT OPINION IN ONCOLOGY, 2001, 13 (06) : 477 - 483
  • [35] Inhibitors of histone deacetylase are potentially effective anticancer agents
    Marks, PA
    Rifkind, RA
    Richon, VM
    Breslow, R
    CLINICAL CANCER RESEARCH, 2001, 7 (04) : 759 - 760
  • [36] Histone deacetylase inhibitors: discovery and development as anticancer agents
    Marks, PA
    Dokmanovic, M
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (12) : 1497 - 1511
  • [37] Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents
    Ververis, Katherine
    Hiong, Alison
    Karagiannis, Tom C.
    Licciardi, Paul V.
    BIOLOGICS-TARGETS & THERAPY, 2013, 7 : 47 - 60
  • [38] Histone deacetylase inhibitors: Emerging anticancer therapeutic agents?
    Kristeleit, Rebecca
    Fong, Peter
    Aherne, G. Wynne
    de Bono, Johann
    CLINICAL LUNG CANCER, 2005, 7 : S19 - S30
  • [39] Clinical development of histone deacetylase inhibitors as anticancer agents
    Drummond, DC
    Noble, CO
    Kirpotin, DB
    Guo, ZX
    Scott, GK
    Benz, CC
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2005, 45 : 495 - 528
  • [40] Anticancer effects of histone deacetylase inhibitors and calpain inhibitor
    Lapinska, Karolina
    Housman, Genevieve
    Heerboth, Sarah
    Longacre, Mckenna
    Sarkar, Sibaji
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 : S16 - S16
12345